Statins ameliorate atherosclerosis induced by inhibition of nitric oxide synthase: Another novel vascular protective mechanism?

International Journal of Cardiology

Volumn 123, Issue 2, 2008, Pages 91-93

  Tousoulis, Dimitris ^a   Antoniades, Charalambos ^b   Stefanadis, Christodoulos ^b  

^a HIPPOKRATION HOSPITAL   (Greece)

^b NONE

Author keywords

Endothelial nitric oxide synthase; Klotho protein; Nitric oxide; Statins

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KLOTHO PROTEIN; NITRIC OXIDE SYNTHASE; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STATINE DERIVATIVE;

ATHEROSCLEROSIS; DOWN REGULATION; DRUG MECHANISM; EDITORIAL; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ATHEROSCLEROSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NITRIC OXIDE SYNTHASE;

EID: 37149042859     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.04.054     Document Type: Editorial

References (18)

1. Kuwahara N., Sasaki S., Kobara M., et al. HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis. Int J Cardiol 123 2 (2007) 84-90 10.1016/j.ijcard.2007.02.029
2. Tentolouris C., Tousoulis D., Goumas G., Stefanadis C., Davies G., and Toutouzas P. l-Arginine in coronary atherosclerosis. Int J Cardiol 75 2-3 (2000) 123-128
3. Siasos G., Tousoulis D., Antoniades C., Stefanadi E., and Stefanadis C. l-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?. Int J Cardiol (2006)
4. Kitamoto S., Egashira K., Kataoka C., et al. Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J Hypertens 18 12 (2000) 1795-1800
5. Antoniades C., Shirodaria C., Warrick N., et al. 5-Methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and eNOS coupling. Circulation 114 11 (2006) 1193-1201
6. Grumbach I.M., Chen W., Mertens S.A., and Harrison D.G. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription. J Mol Cell Cardiol 39 4 (2005) 595-603
7. Usui M., Egashira K., Kitamoto S., et al. Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats. Hypertension 34 4 Pt 1 (1999) 546-551
8. Nagai T., Yamada K., Kim H.C., et al. Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. Faseb J 17 1 (2003) 50-52
9. Mitobe M., Yoshida T., Sugiura H., Shirota S., Tsuchiya K., and Nihei H. Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Exp Nephrol 101 2 (2005) e67-e74
10. Saito Y., Nakamura T., Ohyama Y., et al. In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun 276 2 (2000) 767-772
11. Bendall J.K., Alp N.J., Warrick N., et al. Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression. Circ Res 97 9 (2005) 864-871
12. Tousoulis D., Antoniades C., Koumallos N., et al. Novel therapies targeting vascular endothelium. Endothelium 13 6 (2006) 411-421
13. Tousoulis D., Charakida M., and Stefanadis C. Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure. Int J Cardiol 100 3 (2005) 347-353
14. Hattori Y., Nakanishi N., Akimoto K., Yoshida M., and Kasai K. HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells. Arterioscler Thromb Vasc Biol 23 2 (2003) 176-182
15. Wassmann S., Laufs U., Baumer A.T., et al. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol 59 3 (2001) 646-654
16. Tousoulis D., Antoniades C., Katsi V., et al. The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level. Int J Cardiol 109 1 (2006) 48-52
17. Tousoulis D., Bosinakou E., Kotsopoulou M., Antoniades C., Katsi V., and Stefanadis C. Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina. Int J Cardiol 106 3 (2006) 333-337
18. Briel M., Schwartz G.G., Thompson P.L., et al. Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials. JAMA 295 17 (2006) 2046-2056